Drug offers hope to neck and head cancer sufferers

New immunotherapy treatment twice as effective as chemotherapy against aggressive form of cancer

Drug offers hope to neck and head cancer sufferers

An immunotherapy drug could soon offer hope to patients with currently untreatable head and neck cancers.

Nivolumab was hailed a potential game-changer after it was found to extend the lives of relapsed patients who had run out of therapy options.

Already a subscriber? Sign in

You have reached your article limit.

Unlimited access. Half the price.

Annual €130 €65

Best value

Monthly €12€6 / month

More in this section

Lunchtime News

Newsletter

Keep up with stories of the day with our lunchtime news wrap and important breaking news alerts.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited